Vivo Opportunity, LLC - Apr 29, 2024 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Role
10%+ Owner
Signature
VIVO OPPORTUNITY, LLC, By: /s/ Kevin Dai
Stock symbol
SLNO
Transactions as of
Apr 29, 2024
Transactions value $
-$51,701,551
Form type
4
Date filed
5/1/2024, 01:10 PM
Previous filing
Apr 3, 2024
Next filing
Aug 29, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLNO Common Stock Sale -$35.9M -750K -8.91% $47.80 7.67M Apr 29, 2024 By Vivo Opportunity Fund Holdings, L.P. F1, F2
transaction SLNO Common Stock Sale -$15.9M -351K -4.58% $45.13 7.32M Apr 30, 2024 By Vivo Opportunity Fund Holdings, L.P. F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vivo Opportunity, LLC is the general partner of Vivo Opportunity Fund Holdings, L.P., the record holder of the securities. Vivo Opportunity, LLC disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
F2 The price reported herein is a weighted average price. These shares were sold on the open market in multiple transactions at prices ranging from $45.00 to $53.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (2) to this Form 4.
F3 The price reported herein is a weighted average price. These shares were sold on the open market in multiple transactions at prices ranging from $45.00 to $47.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (3) to this Form 4.